When should asymptomatic patients with HIV infection be treated with zidovudine?
- 22 February 1992
- Vol. 304 (6825) , 456-457
- https://doi.org/10.1136/bmj.304.6825.456
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- A Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1992
- Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group.BMJ, 1992
- Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.BMJ, 1991
- Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDSThe Lancet, 1991
- CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual menAIDS, 1991
- Serial CD4 lymphocyte counts and development of AIDSThe Lancet, 1991
- Applications of a computer simulation model of the natural history of CD4 T-cell number in HIV-infected individualsAIDS, 1991
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.Journal of Clinical Investigation, 1989
- The relationship between male circumcision and HIV infection in African populationsAIDS, 1989